欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
EE/H/0346/002
药品名称
Allopurinol Sandoz
活性成分
Allopurinol 300.0 mg
剂型
Tablet
上市许可持有人
Sandoz Pharmaceuticals d.d. Verovskova Ulica 57 Ljubljana 1000 Slovenia
参考成员国 - 产品名称
Estonia (EE)
互认成员国 - 产品名称
Czechia (CZ)
Slovakia (SK)
Slovenia (SI)
Denmark (DK)
Belgium (BE)
Allopurinol Sandoz 300 mg tabletten
Sweden (SE)
Norway (NO)
Poland (PL)
Latvia (LV)
Allopurinol Sandoz 300 mg tabletes
许可日期
2016/06/02
最近更新日期
2025/02/05
药物ATC编码
M04AA01 allopurinol
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
PubAR
|
Allopurinol Sandoz FI_H_894_01_02_DC Public AR
Date of last change:2024/09/06
Final PL
|
Final PL Allopurinol Sandoz FI_H_894_01_02_DC
Date of last change:2024/09/06
Final SPC
|
Final SPC Allopurinol Sandoz FI_H_894_01_02_DC
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase